Filter sub products categories alphabetically
Azilsartan is a medication introduced for the treatment of hypertension. Azilsartan received approval from the U.S. Food and Drug Administration in 2011 for treating high blood pressure (hypertension).It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which help manage blood pressure by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict. By preventing angiotensin II from binding to its receptors, azilsartan helps relax blood vessels, allowing for easier blood flow and ultimately reducing blood pressure.
MECHANISM OF ACTION
Azilsartan works as an angiotensin II receptor blocker (ARB) by specifically targeting the angiotensin II type 1 receptor (AT1), which plays a key role in the harmful effects of angiotensin II.
Angiotensin II Binding: Under normal circumstances, angiotensin II binds to the AT1 receptors in blood vessels, the heart, kidneys, and other tissues. This causes blood vessels to narrow (vasoconstriction), leading to an increase in blood pressure. It also stimulates the release of aldosterone, a hormone that causes the kidneys to hold onto sodium and water, raising blood pressure further.
Azilsartan's Action: Azilsartan blocks the AT1 receptor, preventing angiotensin II from binding. This blocks the vasoconstrictions effects and reduces the release of aldosterone, which results in vasodilation, or relaxation of blood vessels, which helps to lower blood pressure. Decreased aldosterone secretion, which helps reduce sodium and water retention, further aiding in blood pressure reduction. By blocking the effects of angiotensin II, azilsartan helps relax blood vessels, reduce the strain on the heart, and lower blood pressure.
PHARMACOKINETICS
Absorption:
Azilsartan is easily absorbed after oral intake. It reaches its peak concentration in the blood around 2 to 3 hours after consumption. The drug has a bioavailability of about 60-70% when taken on an empty stomach, with food slightly increasing absorption but not affecting its effectiveness significantly.
Distribution:
Azilsartan is widely distributed throughout the body. It has a high volume of distribution, meaning it spreads extensively in tissues. The drug is highly bound to plasma proteins (around 99%), mainly albumin.
Metabolism:
Azilsartan is minimally metabolized in the liver. It is not significantly affected by cytochrome P450 enzymes, reducing the chance of drug interactions with substances that impact these enzymes. Most of the drug remains in its active form in the body, with only a small portion metabolized.
Elimination:
Azilsartan has a half-life of about 11 hours, allowing for once-daily use. It is mostly eliminated through feces, with less than 1% of the dose excreted in urine. Renal clearance is minimal, as the drug isn’t significantly excreted through the kidneys.
DOSAGE AND ADMINISTRATION
Special Cases:
Take once daily with or without food
DRUG INTERACTIONS
CONTRAINDICATIONS
Hypersensitivity to azilsartan
Pregnancy (especially in the second and third trimesters)
Severe renal impairment (creatinine clearance <30 mL/min)
Bilateral renal artery stenosis
SIDE EFFECTS
Common side effects
Serious side effects may include:
TOXICITY
Toxicity from azilsartan is uncommon but possible, especially in cases of overdose. Symptoms may include: